60
Ensysce Biosciences, Inc. raises $77.2M under Reg D
Company raise · Closed · Offering $77.2M · Sold $77.2M · LA JOLLA, CA · filed 2026-08-20
Placement agent engagedBusiness combination
45
Ensysce Biosciences, Inc. raises $1.1M under Reg D
Company raise · Closed · LA JOLLA, CA · Form D filed 2025-04-14
First raise on EDGARPlacement agent engaged
Why now — by persona
Relevant to: Executive & technical recruiting, B2B software & services sales, Commercial banking / treasury, D&O and management-liability insurance, Outsourced accounting / CFO. Lead card pending.
People on the filing
| Adam Lynn Levin | Director |
| Lee Lynn Rauch | Director |
| D Lynn Kirkpatrick | Executive Officer, Director |
| Andrew Lynn Benton | Director |
| David Lynn Humphrey | Executive Officer |
| Curtis Lynn Rosebraugh | Director |
| William Lynn Chang | Director |
| Steve Lynn Martin | Director |
| Bob Lynn Gower | Director |
Signed by Dr. Lynn Kirkpatrick, President and CEO.
Placement agents / sales compensation: H.C. Wainwright & Co., LLC
Filing contact
The issuer's phone number and address from the filing are shown to subscribers. See plans, or read it on EDGAR.
Other filings by this issuer
45
Ensysce Biosciences, Inc. raises $2.2M under Reg D
Company raise · Closed · Offering $2.2M · Sold $2.2M · LA JOLLA, CA · filed 2025-04-25
Placement agent engaged